Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
XPRSARS-COV2-DOD is a federal award for W6qk Acc-Apg held by Cepheid. Estimated value $4.9M ($4.9M obligated). Current period of performance ends Mar 4, 2022. Place of performance: ABERDEEN MD. Related solicitation W911QY21R0004.
Recompete timing
PublicCurrent PoP ended Mar 4, 2022 (1631 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordCepheid — $254.6M obligated across 5,617 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W911SR22F7004?
W911SR22F7004 (Xprsars-cov2-dod) is a W6qk Acc-Apg award with a potential value of $4.9M, currently held by Cepheid. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W911SR-22-F-7004?
W911SR-22-F-7004 is the dashed form of PIID W911SR22F7004 (Xprsars-cov2-dod), held by Cepheid. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W911SR22F7004?
W6qk Acc-Apg awarded W911SR22F7004 to Cepheid (potential $4.9M).
Who is the incumbent on W911SR22F7004?
Cepheid is the incumbent with $254.6M across 5617 related awards in SCOUT’s public footprint. The current period of performance ends Mar 4, 2022.
When does Cepheid’s W911SR22F7004 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 4, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
